Teva Pharmaceutical Industries LimitedTEVA

Where TEVA's EPS (TTM) sits inside its own 10-year distribution, with the yearly high, low and average.

$37.09+0.74 (+2.04%)Previous close
NYSEHealthcare

TEVA EPS (TTM): current value, 10-year range and year-by-year history

-9.2%/yr10Y CAGR

TEVA's earnings per share declined at 9.2%/year over the last 10 years.

EPS (TTM) History

Historically priceyAbove avgAround avgBelow avgHistorically cheap
TEVA EPS (TTM) historyTEVA EPS (TTM) from Sep 2023 to Jun 2026: low -2, high 1.33, latest 0.6.-2.27-1.3-0.330.631.6Sep 23Mar 24Sep 24Jun 25Dec 25Jun 26med -0.42

TEVA EPS (TTM) by year

Yearly range of TEVA’s eps (ttm) from 2016 to 2026. Over the full period it ranged from -$16.12 to $1.80, averaging -$2.53.

TEVA EPS (TTM) — yearly low, average, high and year-end values
YearLowAverageHighYear-end
2026$0.60$0.97$1.33$0.60
2025-$1.14$0.12$1.20$1.20
2024-$1.45-$0.78-$0.39-$1.45
2023-$2.02-$1.49-$0.49-$0.49
2022-$2.12-$1.20-$0.55-$2.12
2021-$3.63-$1.54$0.66$0.38
2020-$3.68-$2.02$0.00-$3.64
2019-$3.82-$2.93-$0.92-$0.92
2018-$15.66-$9.61-$2.14-$2.14
2017-$16.12-$6.88$0.24-$16.12
2016$0.29$1.05$1.80$0.29

Net income divided by diluted shares outstanding, over the trailing twelve months. Watching EPS trend over time reveals whether earnings are growing, stagnant, or deteriorating — and provides the denominator behind P/E.

FormulaNet Income ÷ Diluted Shares Outstanding
Pro — up to 30-year history

Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.